المؤلفون: Amir Salehi-Najafabadi, Sasan Ghaffari, Hanif Kazerooni

المصدر: International Immunopharmacology

مصطلحات موضوعية: ARDS, CAR, chimeric antigen receptor, SARS, sever acute respiratory syndrome, medicine.medical_treatment, T cell, viruses, Immunology, Cell- and Tissue-Based Therapy, Active immunotherapy, CTL, cytotoxic T cell, ACE2, angiotensin-converting enzyme 2, Virus, Article, GM-CSF, granulocyte monocyte colony-stimulating factor, Immune system, DC, dendritic cell, Adoptive immunotherapy, Pandemic, medicine, Immunology and Allergy, VST, virus-specific T cell, Animals, Humans, NK cell, natural killer cell, Pharmacology, MSC, mesenchymal stromal cell, COVID-19, Coronavirus disease 2019, Transmission (medicine), business.industry, SARS-CoV-2, HLA, human leukocyte antigen, COVID-19, Immunotherapy, medicine.disease, medicine.anatomical_structure, iPSC, inuced pluripotent stem cell, business, ARDS, acute respiratory T cells, Vaccine

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::113904093061b63f33d0ff7ad4e6f9da
http://europepmc.org/articles/PMC8492917